Windtree Therapeutics announces 1-for-50 reverse stock split effective Feb 20, 2025

WINDTREE THERAPEUTICS INC /DE/

Reverse stock split approved by stockholders on Feb 3, 2025; ratio set at 1-for-50.
Effective at 5:00 p.m. ET on Feb 20, 2025; adjusted trading begins Feb 21 under ticker WINT.
Aimed at meeting Nasdaq $1.00 minimum bid price requirement; new CUSIP: 97382D600.
Post-split outstanding shares reduced to approximately 700,000; no fractional shares issued.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/: Filed certificate of amendment to effect a 1-for-50 reverse stock split (effective 2025-02-20).

Change: charter amendment
Effective: 2025-02-20

Exact text from the filing

On February 14, 2025, Windtree Therapeutics, Inc. (the “Company”) filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effectuate a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (“Common Stock”).

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-25-004124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.